z-logo
Premium
Expanding the use of hepatitis C–positive donors and keeping recipient safety at the forefront
Author(s) -
Terrault Norah A.,
Sher Linda
Publication year - 2020
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.15745
Subject(s) - medicine , hepatitis c , virology , immunology
Preemptive use of direct‐acting antiviral therapy to prevent hepatitis C infection among kidney transplant recipients given kidneys from HCV‐viremic donors is highly effective, but an ultra‐short treatment duration is associated with reduced success. See the article from Gupta et al on page 739.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here